Immunsuppressiva Exam
,Multiple-choice questions
Question 1
Which option correctly fills the blank in this technical statement?
Analytical Methodologies and Instrumentation — Multiple reaction monitoring (MRM) transitions, ionization
modes (ESI positive/negative), and internal standard selection (stable ____ standards)
A. High-Performance
B. Methodologies
C. isotope-labeled
D. Cross-reactivity
Correct Answer: C
Full Explanation: Analytical Methodologies and Instrumentation: Multiple reaction monitoring (MRM)
transitions, ionization modes (ESI positive/negative), and internal standard selection (stable isotope-labeled
standards). The required expression is “isotope-labeled”; it completes the specific association described,
rather than substituting a different concept.
Question 2
Which expression completes the analytical or procedural description?
Target Analytes and Clinical Pharmacology — Analytical separation and specificity challenges in ____
A. prophylactic use
B. Pharmacokinetic properties
C. Therapeutic indications
D. chromatographic assays
Correct Answer: D
Full Explanation: Target Analytes and Clinical Pharmacology: Analytical separation and specificity
challenges in chromatographic assays. The required expression is “chromatographic assays”; it completes
the specific association described, rather than substituting a different concept.
Question 3
Identify the missing term that completes the stated relationship.
Target Analytes and Clinical Pharmacology — ____ and mandatory co-quantification alongside parent drug
concentrations
A. gradient elution optimization
B. Cumulative antifungal contribution
C. enterohepatic circulation
D. solid-organ transplantation
Correct Answer: B
Full Explanation: Target Analytes and Clinical Pharmacology: Cumulative antifungal contribution and
mandatory co-quantification alongside parent drug concentrations. The required expression is “Cumulative
antifungal contribution”; it completes the specific association described, rather than substituting a different
concept.
Record 3829 2
,Multiple-choice questions
Question 4
A proposed description contains an incorrect bracketed expression. Which replacement makes the
description accurate?
Mycophenolsäure ([LLE] / Mycophenolic Acid)
A. MPA
B. TDM
C. LLE
D. SPE
Correct Answer: A
Full Explanation: Target Analytes and Clinical Pharmacology: Mycophenolsäure (MPA / Mycophenolic Acid).
The required expression is “MPA”; it completes the specific association described, rather than substituting a
different concept.
Question 5
Select the expression that preserves the technical meaning of this statement.
Analytical Methodologies and Instrumentation — Liquid Chromatography-Tandem Mass Spectrometry (____)
A. DAD
B. LC-MS/MS
C. IMPDH
D. LLE
Correct Answer: B
Full Explanation: Analytical Methodologies and Instrumentation: Liquid Chromatography-Tandem Mass
Spectrometry (LC-MS/MS). The required expression is “LC-MS/MS”; it completes the specific association
described, rather than substituting a different concept.
Question 6
Which choice supplies the missing concept in this description?
Target Analytes and Clinical Pharmacology — Free versus total MPA concentration monitoring relevance in
specialized clinical ____
A. scenarios
B. mycoses
C. acute
D. Analytes
Correct Answer: A
Full Explanation: Target Analytes and Clinical Pharmacology: Free versus total MPA concentration
monitoring relevance in specialized clinical scenarios. The required expression is “scenarios”; it completes
the specific association described, rather than substituting a different concept.
Record 3829 3
, Multiple-choice questions
Question 7
Which expression completes the stated purpose or application?
Module Overview and Regulatory Framework — Statutory requirements and guidelines under the German
Medical Association (RiLiBÄK) for therapeutic drug monitoring (____)
A. ISO
B. AMR
C. TDM
D. EQA
Correct Answer: C
Full Explanation: Module Overview and Regulatory Framework: Statutory requirements and guidelines
under the German Medical Association (RiLiBÄK) for therapeutic drug monitoring (TDM). The required
expression is “TDM”; it completes the specific association described, rather than substituting a different
concept.
Question 8
Which choice supplies the missing concept in this description?
Target Analytes and Clinical Pharmacology — Pharmacokinetics, enterohepatic circulation, protein binding
____, and active glucuronide metabolite interaction (MPAG)
A. generated
B. Triazole
C. mycoses
D. dynamics
Correct Answer: D
Full Explanation: Target Analytes and Clinical Pharmacology: Pharmacokinetics, enterohepatic circulation,
protein binding dynamics, and active glucuronide metabolite interaction (MPAG). The required expression is
“dynamics”; it completes the specific association described, rather than substituting a different concept.
Question 9
Which expression completes the stated purpose or application?
Target Analytes and Clinical Pharmacology — Therapeutic indications for endemic and opportunistic ____
mycoses, as well as prophylactic use in neutropenic patients
A. chromatographic
B. Cumulative
C. active
D. systemic
Correct Answer: D
Full Explanation: Target Analytes and Clinical Pharmacology: Therapeutic indications for endemic and
opportunistic systemic mycoses, as well as prophylactic use in neutropenic patients. The required expression
is “systemic”; it completes the specific association described, rather than substituting a different concept.
Record 3829 4